You are here: Industry Insights > GSK

News List

GSK transfers rights to Ebola vaccines development to US institute pharmaceutical-technology
August 08, 2019
Drug manufacturer GlaxoSmithKline (GSK) transfers its rights to advance the development of the deadly Ebola Zaire, Ebola Sudan and Marburg virus vaccines to the Sabin Vaccine Institute in the US.
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute drugs
August 08, 2019
GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire...
GSK Grants Ebola Vaccine License to Sabin Vaccine Institute contractpharma
August 07, 2019
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines.
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture worldpharmanews
August 07, 2019
The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne...
GSK completes transaction with Pfizer to form new Consumer Healthcare Joint Venture biospectrumasia
August 04, 2019
The Joint Venture brings together two highly complementary portfolios of consumer health brands, including GSK’s Sensodyne, Voltaren and Panadol and Pfizer’s Advil, Centrum and Caltrate
Nucala by GSK receives EU approval for patients with severe eosinophilic asthma biospectrumasia
August 04, 2019
96% of patients in studies preferred self-administration at home over being treated in clinic
GSK closes consumer healthcare JV transaction with Pfizer pharmaceutical-technology
August 02, 2019
GlaxoSmithKline (GSK) has closed the transaction related to the formation of a consumer healthcare joint venture (JV) with Pfizer, with the new company to operate as GSK Consumer Healthcare.
With pharma-consumer split in its sights, GSK hands chairman seat to Symonds fiercepharma
July 28, 2019
Ahead of a massive consumer health spinoff, GlaxoSmithKline’s chairman search is over. The company Wednesday named ex-Novartis and AstraZeneca Chief Financial Officer Jonathan Symonds as its next chairman, effective Sept. 1.
GSK withstands Advair generics thanks to new respiratory meds, Shingrix fiercepharma
July 28, 2019
GlaxoSmithKline's been dreading generic Advair for years, but thanks to its newer respiratory meds and the fast-launching Shingrix vaccine, the company's top line is so far managing to hold its own.
GSK appoints Jonathan Symonds as non-executive chairman of Board biospectrumasia
July 28, 2019
The appointment was approved by the board and follows a thorough succession process undertaken by the Nominations Committee, led by Vindi Banga, the company’s senior independent director (SID)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page